Back
Open Access

Effect of finerenone on morbidity and mortality in chronic kidney disease and type 2 diabetes: FINE-HEART analysis of 3 randomized clinical trials

Session: ePosters in cardiovascular disease in special populations (3)
Topic: Renal Failure and Cardiovascular Disease
Speaker: Doctor J. Ostrominski (Boston, US)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor John Ostrominski

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
1 presentation
0 follower

4 more presentations in this session

Histopathologic insights into AVF functionality and heart failure in end-stage renal disease

Speaker: Mrs V. Samsone (Vilnius, LT)

Access
Abstract
Like
Thumbnail

Effects of dapagliflozin on renal function in heart transplant recipients.

Speaker: Doctor A. Gutowska (Gdansk, PL)

Access
Abstract
Like
Thumbnail

Chemotherapy versus tumour burden: evaluating their roles in cardiovascular risk enhancement for breast cancer patients

Speaker: Doctor R. Fernandes (Coimbra, PT)

Access
Abstract
Like
Thumbnail

Exploring the hemoglobin-cardiovascular link in chronic kidney disease patients

Speaker: Doctor T. Pereira dos Santos (Coimbra, PT)

Access
Abstract
Like
Thumbnail

Access the full session

ePosters in cardiovascular disease in special populations (3)

Speakers: Doctor J. Ostrominski, Mrs V. Samsone, Doctor A. Gutowska, Doctor R. Fernandes, Doctor T. Pereira dos Santos
Access
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources